XML 127 R43.htm IDEA: XBRL DOCUMENT
v3.20.4

Share-based compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2020
Share-Based Payment Arrangements [Abstract] |
Expense associated with each component | The expense associated with each component is as follows:
|  | 2020 |  | 2019
|  | $ |  | $
Stock options |  | 1,059 |  |  | 550 |
DSUs |  | 560 |  |  | 109 |
|  | 1,619 |  |  | 659 |
Changes in stock options | The changes in the number of stock options during the fiscal year ended December 31, 2020 and 2019 were as follows:
| 2020 |  | 2019
| Number of options |  | Weighted average exercise price |  | Number of options |  | Weighted average exercise price
| # |  | C$ |  | # |  | C$
Options outstanding – January 1 | 1,692,347 |  |  | 5.41 |  |  | 1,546,700 |  |  | 0.98 |
Options granted | 65,050 |  |  | 29.04 |  |  | 601,347 |  |  | 13.59 |
Options forfeited | (48,325) |  |  | 10.19 |  |  | (21,000) |  |  | 2.14 |
Options exercised | (192,431) |  |  | 1.77 |  |  | (434,700) |  |  | 1.13 |
Options outstanding – December 31 | 1,516,641 |  |  | 6.73 |  |  | 1,692,347 |  |  | 5.41 |
Options exercisable – December 31 | 917,162 |  |  | 2.38 |  |  | 943,300 |  |  | 0.99 |
Stock options outstanding and exercisable by range of exercise prices | The following table is a summary of the Company’s share options outstanding as at December 31, 2020:
Options outstanding |  | Options exercisable
Exercise price range |  | Number outstanding |  | Weighted average remaining contractual life (years) |  | Exercise price range |  | Number exercisable
C$ |  | # |  | # |  | C$ |  | #
0.0001 - 1.09 |  | 899,300 |  |  | 6.30 |  | 0.0001 - 1.09 |  | 810,900 |
8.86 - 11.06 |  | 215,420 |  |  | 9.96 |  | 8.86 - 11.06 |  | 36,400 |
15.79 - 16.00 |  | 377,089 |  |  | 8.78 |  | 15.79 - 16.00 |  | 69,862 |
26.43 - 64.19 |  | 24,832 |  |  | 9.89 |  | 26.43 - 64.19 |  | — |
|  | 1,516,641 |  |  | 7.50 |  |  |  | 917,162 |
The following table is a summary of the Company’s share options outstanding as at December 31, 2019:
Options outstanding |  | Options exercisable
Exercise price range |  | Number outstanding |  | Weighted average remaining contractual life (years) |  | Exercise price range |  | Number exercisable
C$ |  | # |  | # |  | C$ |  | #
0.0001 - 1.09 |  | 1,079,400 |  |  | 7.73 |  | 0.0001 - 1.09 |  | 934,100 |
3.09 - 3.43 |  | 23,200 |  |  | 8.95 |  | 3.09 - 3.43 |  | 9,200 |
8.86 - 11.06 |  | 181,600 |  |  | 11.18 |  | 8.86 - 11.06 |  | — |
15.79 - 16.00 |  | 408,147 |  |  | 9.79 |  | 15.79 - 16.00 |  | — |
26.43 - 64.19 |  | — |  |  | — |  |  | 26.43 - 64.19 |  | — |
|  | 1,692,347 |  |  | 8.38 |  |  |  | 943,300 |
Number and weighted average remaining contractual life of stock options outstanding and exercisable | The following table is a summary of the Company’s share options outstanding as at December 31, 2020:
Options outstanding |  | Options exercisable
Exercise price range |  | Number outstanding |  | Weighted average remaining contractual life (years) |  | Exercise price range |  | Number exercisable
C$ |  | # |  | # |  | C$ |  | #
0.0001 - 1.09 |  | 899,300 |  |  | 6.30 |  | 0.0001 - 1.09 |  | 810,900 |
8.86 - 11.06 |  | 215,420 |  |  | 9.96 |  | 8.86 - 11.06 |  | 36,400 |
15.79 - 16.00 |  | 377,089 |  |  | 8.78 |  | 15.79 - 16.00 |  | 69,862 |
26.43 - 64.19 |  | 24,832 |  |  | 9.89 |  | 26.43 - 64.19 |  | — |
|  | 1,516,641 |  |  | 7.50 |  |  |  | 917,162 |
The following table is a summary of the Company’s share options outstanding as at December 31, 2019:
Options outstanding |  | Options exercisable
Exercise price range |  | Number outstanding |  | Weighted average remaining contractual life (years) |  | Exercise price range |  | Number exercisable
C$ |  | # |  | # |  | C$ |  | #
0.0001 - 1.09 |  | 1,079,400 |  |  | 7.73 |  | 0.0001 - 1.09 |  | 934,100 |
3.09 - 3.43 |  | 23,200 |  |  | 8.95 |  | 3.09 - 3.43 |  | 9,200 |
8.86 - 11.06 |  | 181,600 |  |  | 11.18 |  | 8.86 - 11.06 |  | — |
15.79 - 16.00 |  | 408,147 |  |  | 9.79 |  | 15.79 - 16.00 |  | — |
26.43 - 64.19 |  | — |  |  | — |  |  | 26.43 - 64.19 |  | — |
|  | 1,692,347 |  |  | 8.38 |  |  |  | 943,300 |
Number of DSUs granted | The following table presents information concerning the number of DSUs granted by the Company:
| #
DSUs – January 1, 2019 | — |
Granted (at C$16 per unit) | 36,250 |
DSUs – December 31, 2019 | 36,250 |
Granted (at C$26.43 - $45.54 per unit) | 15,833 |
Released (at C$16.00 - 45.54 per unit) | (5,883) |
Forfeited (at C$38.87 per unit) | (2,058) |
DSUs - December 31, 2020 | 44,142 |

X
- Definition Share-Based Payment Arrangements [Abstract] + References No definition available. + Details
Name: | docebo_ShareBasedPaymentArrangementsAbstract
Namespace Prefix: | docebo_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_b&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the range of exercise prices for outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 45 -Subparagraph d -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_45_d&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfRangeOfExercisePricesOfOutstandingShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The explanation that enables users of financial statements to understand the effect of share-based payment transactions on the entity's profit (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2020-01-01 -Paragraph 50 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2020-en-r&anchor=para_50&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration